Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Tazobactam × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

pembrolizumab 532 Specimen Handling 490 Magnetic Resonance Spectroscopy 423 Carboplatin 343 Cyclophosphamide 324 Biopsy 293 Cisplatin 287 Paclitaxel 257 Nivolumab 243 Gemcitabine 224 Radiotherapy 212 Bevacizumab 189 Dexamethasone 187 fludarabine 181 venetoclax 175 Oxaliplatin 155 Docetaxel 152 Fluorouracil 149 durvalumab 146 atezolizumab 146 Rituximab 144 Pemetrexed 139 Capecitabine 137 Doxorubicin 129 Radiation 127 Lenalidomide 124 Standard of Care 119 Prednisone 117 Radiosurgery 115 Drug Therapy 114

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡